Depression remains a major global health challenge, with a considerable number of individuals failing to respond to conventional therapies such as psychotherapy and pharmacotherapy. This persistent lack of efficacy underscores the need for innovative strategies and a deeper understanding of the mechanisms driving treatment resistance. TRD (or DTD) exemplifies the complexity of this condition, emphasizing the urgency for tailored interventions.
About the author(s)
Amourie Prentice
Amourie Prentice did her PhD at Synaeda Psycho Medisch Centrum, Brainclinics Foundation in collaboration with Maastricht University.
